Cargando…
Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate-resistant bone marrow
To develop a highly efficient means for generating methotrexate resistant (MTXr) hematopoietic cells in vivo, a recombinant retroviral genome was constructed that encodes a MTXr dihydrofolate reductase (DHFRr). Cell lines producing high titers of virus capable of transmitting the DHFR gene were gene...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1987
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2188648/ https://www.ncbi.nlm.nih.gov/pubmed/3298524 |
Ejemplares similares
-
Anabolic Steroids and Bone Marrow Toxicity During Therapy with Methotrexate
por: Rawbone, R. G., et al.
Publicado: (1972) -
Notch2 Blockade Mitigates Methotrexate Chemotherapy-Induced Bone Loss and Marrow Adiposity
por: Peymanfar, Yaser, et al.
Publicado: (2022) -
Bone Fragment Co-transplantation Alongside Bone Marrow Aspirate Infusion Protects Kidney Transplant Recipients
por: Luo, Xianzhang, et al.
Publicado: (2021) -
Reversal of Methotrexate Cytotoxicity to Human Bone Marrow Cells and Leukemic K562 Cells by Leucovorin: Methotrexate Polyglutamates Formation as a Possible Important Factor
por: Koizumi, Shoichi, et al.
Publicado: (1990) -
A Comparison of Vitamin A and Leucovorin for the Prevention of Methotrexate-Induced Micronuclei Production in Rat Bone Marrow
por: Madhyastha, Sampath, et al.
Publicado: (2008)